Is the six-minute step test able to reflect the severity and symptoms based on cat score?

Heart Lung. 2023 Mar-Apr:58:28-33. doi: 10.1016/j.hrtlng.2022.10.010. Epub 2022 Nov 10.

Abstract

Background: This is the first study to investigate the performance of 6MST in COPD patients divided into different symptom severity groups based on the CAT questionnaire score.

Objectives: To evaluate the relationship between the degree symptomatology using the chronic obstructive pulmonary disease (COPD) Assessment Test (CAT) with the six- minute step test (6MST) in COPD patients.

Methods: This is a cross-sectional study in which 59 patients with COPD were evaluated. The groups were stratified according to the subsequent cutoff points: CAT <10 (little impact) n= 22; CAT 11-20 (moderate impact) n=20; CAT <20 (large impact) n=17. During 6MST the individuals were instructed to go up and down a single step with a height of 20 centimeters (cm).

Results: Comparing the groups in relation to performance on the 6MST, the number of climbs on the step were significantly higher in the CAT group <10 when compared to the CAT group >20, the variation in HR between rest and peak exercise (∆ HRpeak- rest) was lower in the CAT>20 group compared to the CAT<10 group and the CAT 11- 20 group. We found direct relationships between the number of ascents and descents in the 6MST vs the CAT score (r=0.35, p=0.007); and 6MST vs degree of obstruction of %FEV1 (r-0.46, p=0.002) We verified a linear regression model in which the FEV1 (L) and the CAT score influenced 29% in the performance of the 6MST.

Conclusion: The COPD severity represented by the FEV1 and the CAT score are associated and influenced by 29% the performance of 6-minute step test. Our findings may have important implications for the clinical evaluation of these patients as well as for rehabilitation.

Keywords: COPD assessment test; Chronic Obstructive pulmonary disease; Six-minute step test.

MeSH terms

  • Cross-Sectional Studies
  • Exercise
  • Exercise Test*
  • Humans
  • Pulmonary Disease, Chronic Obstructive*
  • Respiratory Function Tests